7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Integrin αVβ3 and αVβ5 are required for leukemia inhibitory factor-mediated the adhesion of trophoblast cells to the endometrial cells.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The embryo implantation including adhesion between trophoblast and endometrium is a crucial process for the successful pregnancy. LIF and adhesion molecules including integrins are known as significant factors for embryo implantation. However, the function of LIF on the regulation of adhesion molecule expression and promotion of trophoblast adhesion to endometrial cells has not been fully elucidated. Here we show that LIF significantly induced mRNA expression of ITGAV, ITGB3, and ITGB5 in endometrial cells, as evidenced by RT-PCR and qRT-PCR analysis. Based on the results from treatment of antagonist for LIF receptor (hLA), LIF positively regulates expression of integrin αV, β3, and β5, and adhesion of the human trophectoderm-derived JAr cells to endometrial Ishikawa cells. Furthermore, the adhesion between trophoblastic cells and LIF-stimulated endometrial cells was significantly reduced by neutralization of LIF-mediated integrin β3 and β5 expression on endometrial cell surface with integrin subunit β3 and β5 antibodies. Taken together, we firstly demonstrate that LIF enhances the adhesion of trophoblastic cells to endometrial cells by up-regulating expression of integrin heterodimer αVβ3 and αVβ5, indicating the promotion of endometrial receptivity for embryo implantation.

          Related collections

          Author and article information

          Journal
          Biochem. Biophys. Res. Commun.
          Biochemical and biophysical research communications
          Elsevier BV
          1090-2104
          0006-291X
          Jan 22 2016
          : 469
          : 4
          Affiliations
          [1 ] School of Korean Medicine and Healthy Aging Korean Medicine Research Center, Pusan National University, Yangsan, Gyeongsangnam-do 626-780, Republic of Korea.
          [2 ] Laboratory of Molecular Toxicology, School of Pharmacy, SungKyunKwan University, Suwon, Gyeonggi-do, Republic of Korea.
          [3 ] School of Korean Medicine and Healthy Aging Korean Medicine Research Center, Pusan National University, Yangsan, Gyeongsangnam-do 626-780, Republic of Korea. Electronic address: hjchoi@pusan.ac.kr.
          [4 ] School of Korean Medicine and Healthy Aging Korean Medicine Research Center, Pusan National University, Yangsan, Gyeongsangnam-do 626-780, Republic of Korea. Electronic address: hagis@pusan.ac.kr.
          Article
          S0006-291X(15)31108-6
          10.1016/j.bbrc.2015.12.103
          26723254
          40efedba-566c-44b3-8a9b-8e61060d120a
          History

          Implantation,Endometrium,Trophoblast,Leukemia inhibitory factor,Integrin

          Comments

          Comment on this article